Live Breaking News & Updates on Olaf althaus

Stay informed with the latest breaking news from Olaf althaus on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Olaf althaus and stay connected to the pulse of your community

DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics Announces Changes to Management


DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics Announces Changes to Management
Atriva Therapeutics Announces Changes to Management
13.04.2021 / 09:30
Atriva Therapeutics Announces Changes to Management
- Olaf Althaus appointed Chief Financial Officer
- Stephan Stenglein, M.D., recently joined as Chief Medical Officer
- Proven track record and 20+ years of experience in their respective fields of expertise
Tübingen (Germany), April 13, 2021 - Atriva Therapeutics GmbH, a biopharmaceutical company that is pioneering the development of host-targeting antiviral therapies, today announced two changes to its management team. Olaf Althaus was appointed Chief Financial Officer, effective May 2020, while Stephan Stenglein, M.D., was named Chief Medical Officer, effective February 2021.

Frankfurt-am-main , Hessen , Germany , Haasbach , Nordrhein-westfalen , London , City-of , United-kingdom , Eva-bauer-raimund-gabriel , Olaf-althaus , Stephan-stenglein , Kostenloser-wertpapierhandel